MS vs TMO: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
TMO |
| Current Price |
$206.27 |
$658.32 |
| Fair Value Estimate |
$239.00 |
$863.34 |
| Upside to Fair Value |
+15.9%
|
+31.1%
|
| Market Cap |
$325.4B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
23.5x
|
25.9x
|
| Price / Sales |
2.6x
|
5.3x
|
| Price / FCF |
—
|
33.4x
|
| Revenue Growth YoY |
+22.4%
|
+10.5%
|
| Gross Margin |
59.7%
|
40.4%
|
| Operating Margin |
20.7%
|
17.7%
|
| Return on Equity |
18.1%
|
13.4%
|
| Dividend Yield |
2.01% |
0.28% |
| FCF Yield |
—
|
3.0%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
MS |
TMO |
| Zone Low |
$179.25 |
$647.50 |
| Zone High |
$203.15 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|